Sign up for our structured smoking cessation program, which includes an initial assessment, personalized support, email follow-up over several weeks, a discussion forum, peer support on Whatsapp, and a review of your progress at the end of the program.
Step 1. Baseline assessment
We begin by assessing your personal profile, your smoking habits, your level of nicotine dependence, your motivation, your confidence in your ability to quit, and your previous attempts to quit smoking, then we set your goals for the program.
Step 2. Individualized feedback
Then, based on your responses, you will receive your personalized smoking cessation plan that translates the assessment into practical recommendations, motivational feedback and a tailored cessation action plan
Step 3: Follow-up via email and a discussion forum
After the initial feedback report, you will regularly receive individually-tailored emails over 6 months, designed to keep you motivated, reinforce and sustain the change, as well as advice aimed at preventing relapses. You will also be invited to join our discussion forum and our Whatsapp group, where you can talk about the challenges you face while trying to quit smoking, find support from other members, and help and support them in return.
Step 4. Evaluation of outcomes and new quit attempt if needed
At the end of the program, we will review your situation: whether you have quit smoking or cut back, your attempts to quit, your motivation, any relapses, and your confidence in your ability to quit smoking or remain an ex-smoker. And we will help those who have relapsed to prepare for another attempt to quit.
To start the program, answer our baseline questionnaire:
Allen Carr’s Easyway method is one of the best-known approaches to stopping smoking without medication or nicotine replacement products. Its central idea is quite different from conventional smoking cessation programmes: instead of teaching smokers to resist the urge to smoke, it aims to change the way they think about smoking so that they no longer feel the need to smoke. But does it work?
What is the Easyway method ?
The method was developed by Allen Carr, a former heavy smoker who quit in 1983. It is best known through his book The Easy Way to Stop Smoking, first published in 1985 and which has sold over 13 million copies, and through group seminars and online courses.
The approach is based on the idea that smokers continue smoking largely because they believe cigarettes provide pleasure, relieve stress, help them concentrate or offer comfort. According to Carr, these perceived benefits are largely an illusion: smoking mainly relieves the discomfort caused by nicotine withdrawal, creating a cycle of dependence.
During a seminar, participants are encouraged to question their beliefs about smoking and understand how nicotine addiction works. Rather than relying on willpower or seeing cigarettes as something they must give up, they are encouraged to view quitting as gaining freedom from an addiction. The method also aims to remove the fear of withdrawal, weight gain and life without cigarettes.
Unlike most conventional programmes, Allen Carr’s method does not routinely use nicotine replacement therapy or medication. Participants are generally encouraged to continue smoking until the end of the session, when they are asked to smoke their last cigarette.
Is there a scientific basis for the method?
The method’s explanation of nicotine addiction has some similarities with established psychological concepts. In particular, questioning beliefs about smoking and changing the way a person responds to cravings are recognised elements of cognitive behavioural approaches.
However, Allen Carr’s method was not developed on the basis of scientifically validated psychological principles, and many experts believe that some of its underlying assumptions are incorrect. For example, the idea that quitting can be entirely free of withdrawal symptoms is not consistent with what is known about nicotine addiction. Many smokers experience cravings, irritability, anxiety, sleep disturbances or difficulty concentrating after stopping.
What do scientific studies show?
Despite the method’s popularity, relatively few clinical studies have examined its effectiveness. A systematic review identified only six studies suitable for analysis, including two randomised controlled trials:
A large British trial, involving 620 smokers, compared a 4 to 6 hour Easyway seminar with a specialist Stop Smoking Service offering behavioural support and nicotine replacement therapy. After six months, the quit rates were 19.4% and 14.8%, respectively. The difference was not statistically significant, meaning that the study could not establish that either approach was more effective.
In an Irish trial, 300 smokers were randomly assigned to either a in-person, 5 hours single-session Easyway seminar or to the online National Smoking Cessation Service ‘Quit.ie’. The researchers found higher quit rates among participants attending the seminar than among those using the online service. After one year, 22% of the in-person seminar participants had stopped smoking, compared with 11% in the online comparison group.There is, however, one important difference between the two groups that makes them incomparable: a five-hour in-person session, regardless of its content, will inevitably have a greater impact than an online system, especially if participation rates in online activities are low, which was the case in this study.
Evidence for the book alone is particularly limited. Reading it has not yet been shown convincingly to increase long-term quit rates.
Should you try Allen Carr’s method?
Allen Carr’s method emphasis on challenging the perceived benefits of cigarettes may be helpful for some smokers, but claims of exceptionally high success rates are unfounded. Scientific data indicate that the Easyway seminar is no more effective than other in-person methods. Furthermore, the fact that this method emphasizes avoiding nicotine replacement therapies may be counterproductive.
Possenti I, Scala M, Lugo A, Clancy L, Keogan S, Gallus S. The effectiveness of Allen Carr’s method for smoking cessation: A systematic review. Tob Prev Cessat. 2023 Sep 29;9:29. https://doi.org/10.18332/tpc/172314
Frings D, Albery IP, Moss AC, et al. Comparison of Allen Carr’s Easyway programme with a specialist behavioural and pharmacological smoking cessation support service: a randomized controlled trial. Addiction. 2020;115(5):977–985. https://doi.org/10.1111/add.14897
Hypnosis is often promoted as a way to stop smoking by changing the thoughts and habits associated with cigarettes. Some people turn to it because they want to quit without medication, while others hope it will help them overcome cravings or avoid relapsing after quitting. But does hypnosis really work? What does the scientific evidence say?
What is hypnosis?
Hypnosis, also called hypnotherapy, involves guiding a person into a state of deep relaxation and focused attention. During a session, the therapist may use suggestions intended to strengthen the desire to stop smoking, change the way cigarettes are perceived or help the person respond differently to situations that trigger the urge to smoke. Contrary to a common misconception, hypnosis does not involve losing control or being forced to do something against your will.
Is hypnosis effective to quit smoking?
Scientific research has not yet established that hypnosis is an effective way to quit smoking. A Cochrane systematic review (an authoritative source), published in 2019, examined 14 studies involving nearly 2,000 people. It found no reliable evidence that hypnosis helped more people quit than other forms of support, such as counselling. The quality of the available studies was generally low, making it difficult to draw firm conclusions.
The World Health Organization’s 2024 guidelines also found insufficient evidence to recommend hypnosis for smoking cessation.
Should you use hypnosis to quit smoking?
Some people may find the relaxation and focused attention helpful when dealing with stress or the habitual aspects of smoking. However, hypnosis should not replace treatments that have demonstrated effectiveness, such as nicotine replacement therapy, prescription medication such as varenicline and cytisine, and behavioural counselling. If you decide to try it, consider it a complement to established treatments rather than a substitute for them.
Please use the Comments field below to share your experience or to suggest improvements to this article.
Rate this article by clicking on the desired number of stars: (No Ratings Yet)
Acupuncture is sometimes presented as a natural way to stop smoking, reduce nicotine cravings and ease withdrawal symptoms. It is particularly popular among people looking for an alternative to nicotine replacement products or medication. But does it actually help people quit smoking? What does the scientific evidence tell us?
What is acupuncture?
Acupuncture is a traditional Chinese practice in which very fine needles are inserted into specific points on the body. For smoking cessation, treatment often involves stimulating points around the ears, hands and other parts of the body. Some practitioners also use ear acupuncture (auricular acupuncture), in which needles are placed at specific points on the outer ear.
The treatment is based on the idea that stimulating these points may influence the nervous system and help regulate certain bodily functions. In the context of smoking cessation, it is intended to reduce nicotine cravings, anxiety, irritability and other withdrawal symptoms.
What does the scientific evidence say?
Acupuncture has been studied in numerous clinical trials, but there is little convincing evidence that it helps smokers quit. A Cochrane review (which is an authoritative souce) that included 38 randomized clinical trials concluded that:
The review did not find consistent evidence that active acupuncture or related techniques increased the number of people who could successfully quit smoking. However, some techniques may be better than doing nothing, at least in the short term, and there is not enough evidence to dismiss the possibility that they might have an effect greater than placebo
In its 2024 smoking cessation guidelines, the World Health Organization (WHO) concluded that the evidence is currently insufficient to recommend acupuncture or acupressure for quitting tobacco.
Should you try acupuncture to quit smoking?
However, if you find that acupuncture helps you relax or can provide support during the quitting process, you may want to try it, but acupuncture should not be used as a substitute for treatments that have been proven effective for smoking cessation. Nicotine replacement therapy, medications such as varenicline and cytisine, and behavioural support have much stronger scientific evidence behind them.
If you decide to try acupuncture, choose a qualified practitioner who uses sterile, single-use needles. Acupuncture is generally considered safe when performed by a properly trained professional, although minor bleeding, bruising or temporary soreness can occur.
Please use the Comments field below to share your experience or to suggest improvements to this article.
Rate this article by clicking on the desired number of stars: (No Ratings Yet)
White AR, Rampes H, Liu JP, Stead LF, Campbell J. Acupuncture and related interventions for smoking cessation. Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD000009. https://doi.org/10.1002/14651858.CD000009.pub4.
Cytisine is authorized for smoking cessation in 34 countries, and is included in the WHO’s list of essential medicines. It is manufactured and distributed by relatively small pharmaceutical companies rather than by “big pharma”:
It is sold under the brand name Tabex since the 1960s (manufacturer: Sopharma in Bulgaria),
and more recently Desmoxan (manufacturer: Aflofarm in Poland), and the same product by Aflofarm is sold under different brand names in different countries: – Defumoxan in Romania, – Liberisan in Hungary, – Tadocitan in Spain, – Asmoken in Austria and Germany, – Decigatan in Belgium and the Netherlands, – Dextazin in Portugal, and – generic Cytisine in the UK.
In France, the product Liberostin obtained the official AMM approval, but the product is not yet on the market.
The Polish firm Adamed Pharma produces cytisine tablets under the brand names Recigar (sold in also in Russia and Ukraine), and also Cytisinicline Adamed, Glavrinxa and Belnifrem in the UK, distributed by Viatris.
In Thailand, the Government Pharmaceutical Organization produces tablets under the brand name Cytisine GPO.
In Australia, Quit4Good sells cytisine tablets that dissolve under the tongue, Nicoiq sells oral strips, and QSN sells cytisine tablets under the name NaturQuit.
In the USA, the company Achieve Life Sciences conducted several randomized trials with the objective of obtaining FDA approval for its cytisinicline product.
In some other countries, cytisine is not available as a commercial product, but is available as a compounded magistral preparation dispensed by pharmacists on medical prescription.
There are probably other brands and manufacturers, so please tell us if you know of any, using the “Comments” field below.
Please use the Comments field below to share your experience or to suggest improvements to this article.
Rate this article by clicking on the desired number of stars: (No Ratings Yet)
Electronic cigarettes (e-cigarettes or vapes) are an alternative to traditional cigarettes and a tool to help smokers quit.
What are e-cigarettes?
E-cigarettes are devices that heat a liquid (usually containing nicotine, flavorings, and other chemicals) to produce an aerosol that is inhaled. Unlike conventional cigarettes, they do not burn tobacco and therefore do not produce tar or carbon monoxide—two of the most harmful components of cigarette smoke. The aerosol still contains substances that can affect health, although at much lower levels than cigarette smoke.
How effective are e-cigarettes for quitting smoking?
Evidence suggests that e-cigarettes can help some smokers quit, particularly when compared to no support or to traditional nicotine replacement therapies. Clinical trials have shown that smokers using nicotine-containing e-cigarettes are more likely to quit than those using nicotine patches or gum.
Behavioral support—such as counseling or structured quit programs—significantly improves success rates when combined with e-cigarettes.
Who should consider using e-cigarettes?
E-cigarettes may be appropriate for smokers who are looking for an alternative source of nicotine with fewer toxic exposures, they are not recommended for non-smokers.
How to use e-cigarettes effectively to quit
First, choose a device, flavor and nicotine level that adequately replaces your cigarette and prevent cravings. If the nicotine dose is too low, you may relapse to smoking. Take our test to determine the nicotine strength you need in your e-liquid.
Second, set a clear goal to quit smoking completely. Some people switch from traditional cigarettes to e-cigarettes within a few days or weeks. Others, however, may need to use both e-cigarettes and cigarettes (dual use)for a while before they can quit smoking completely, which is perfectly normal.
Third, use the e-cigarette regularly to prevent and manage cravings, rather than waiting until urges become overwhelming.
Fourth, combine vaping with behavioral strategies. Identify triggers, change routines, and develop coping mechanisms, just as you would with any quit attempt.
How long should e-cigarettes be used after quitting?
There is no “ideal” duration; some people use e-cigarettes as a temporary solution, while for others, they replace cigarettes and become a permanent habit.
Gradual reduction in frequency or nicotine strength is not recommended if you still experience nicotine withdrawal symptoms when you reduce. Some individuals may need long-term use at a sufficient dosage, particularly those with a strong dependence on nicotine.
The basic principle is to take a sufficient dose of nicotine for a long enough period to avoid withdrawal symptoms and prevent a relapse into smoking.
Reference:
Lindson N, Livingstone-Banks J, Butler AR, McRobbie H, Bullen CR, Hajek P, Wu AD, Begh R, Theodoulou A, Notley C, Rigotti NA, Turner T, Fanshawe T, Hartmann-Boyce J. Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews 2025, Issue 11. Art. No.: CD010216. DOI: 10.1002/14651858.CD010216.pub10.
Quitting smoking is best done with the support of a therapist. While nicotine replacement therapies and medications often play a role, a powerful non-pharmacological tool is increasingly being recognized for its effectiveness: Cognitive Behavioral Therapy (CBT).
CBT, at its core, is a structured, goal-oriented approach to psychological treatment. But when applied to smoking cessation, it becomes a sophisticated strategy designed to dismantle the mental machinery that keeps the habit alive.
The Core Idea: Thoughts, Feelings, and Actions
CBT operates on the principle that our thoughts, feelings, and actions are interconnected. In the context of smoking, the act of lighting up isn’t just a physical craving; it’s often the final step in a chain of automatic thoughts and emotional responses.
For example, a stressful day at work might trigger the thought, “A cigarette will calm me down.” This thought leads to feelings of anxiety relief and, finally, the action of smoking. CBT aims to break this chain by identifying and modifying the unhelpful thoughts and behaviors that serve as “triggers.”
How a Session Unfolds
CBT for smoking cessation is typically delivered over several sessions, either individually or in a group setting. It is not a casual chat; it involves active work and strategy building.
First, the therapist and patient establish a precise functional analysis of the smoking habit. This means meticulously tracking when, where, and why the person smokes. It seeks to answer the crucial question: what function does the cigarette actually serve? Is it a social crutch, a mechanism for managing stress, or a way to fight boredom?
Once these triggers are mapped out, the core techniques of CBT come into play:
Cognitive Restructuring: This involves challenging and replacing the nicotine-related beliefs that have been ingrained over years. For instance, the thought “I can’t handle stress without a cigarette” is challenged with evidence and alternative, more constructive coping statements, such as “I can manage stress by taking a short walk or using deep breathing.”
Behavioral Skills Training: Patients are taught concrete strategies to avoid and cope with high-risk situations. This includes stimulus control—changing environmental cues that trigger smoking (like moving an armchair where they always smoked)—and coping skills training, which equips them with alternatives to smoking when a craving hits. This might be a physical activity, a relaxation technique, or a simple distraction method.
Relapse Prevention: This is a crucial final phase. It prepares the individual for inevitable slip-ups or cravings by viewing them not as failures, but as temporary setbacks that can be learned from. Patients develop a tailored “escape plan” for high-risk situations in the future.
Who Benefits and Who Should Be Cautious?
CBT has demonstrated significant effectiveness, particularly when combined with pharmacological aids like Varenicline or Nicotine Replacement Therapy (NRT). Studies show that by addressing both the physical addiction and the psychological dependence, the chances of sustained abstinence are substantially higher.
It is highly suitable for:
Individuals with strong psychological dependence: Those whose smoking is heavily tied to emotional states, stress, or specific environments.
Smokers with co-occurring anxiety or depression: CBT is often a first-line treatment for these conditions, making it a powerful dual-purpose tool.
Those who have tried other methods and relapsed: CBT offers a fresh approach by focusing on the underlying thought patterns that led to the return of the habit.
It may be less suitable for:
Individuals unwilling to engage in introspection: CBT requires motivation and a willingness to examine one’s own thoughts and challenge long-held beliefs. It is an active process that requires homework and commitment.
Rate this article by clicking on the desired number of stars: (1 votes, average: 5.00 out of 5)
Please use the “Comments” field below to share your experience or suggest improvements to this article.
Since the 1970s, nicotine replacement therapy (NRT) has been helping smokers quit. Nicotine gums are designed to treat physical dependence on nicotine by releasing a controlled dose through the oral mucosa, thus avoiding the thousands of harmful chemicals present in tobacco smoke and reducing cravings and other nicotine withdrawal symptoms.
What is Nicotine Gum and How Does It Work?
Nicotine gum is exactly what its name implies: a piece of specially formulated chewing gum containing medicinal nicotine. Unlike regular chewing gum, it is designed to be “parked” between the cheek and the gum after a few chews, allowing the nicotine to be absorbed slowly into the bloodstream. This process helps to smooth out the craving cycles that derail many quit attempts. The active ingredient, nicotine, is present in a polacrilex resin that controls its release. The gum often contains flavorings, sweeteners, and buffering agents to facilitate absorption and manage taste.
Crucially, the gum’s approval extends beyond simply quitting smoking cold turkey. It is also sanctioned for smoking reduction, allowing highly dependent smokers to cut back their cigarette consumption before fully stopping, and for pre-treatment (or ‘pre-quitting’), where users start the gum a week or two before their target quit date to lower their dependence baseline, thereby increasing the chances of success when the final stop occurs.
Dosage: The Critical Difference Between Success and Relapse
The efficacy of nicotine gum hinges on using the correct strength and quantity. It is available in two main dosages: 2 mg and 4 mg. The choice between these is directly tied to the individual’s level of nicotine dependence, which is typically measured by the time elapsed between waking up and smoking the first cigarette. We have developed a questionnaire to help you determine how much nicotine you need and which nicotine gum strength and amount is best for you.
Smokers who light up their first cigarette more than 30 minutes after waking are generally advised to start with the 2 mg dose. However, those who smoke their first cigarette within 30 minutes of waking, or who smoke more than 20 cigarettes per day, should begin with the 4 mg strength.
This emphasis on starting with an adequate dose is vital because underdosing is a primary reason for treatment failure and relapse to smoking. If the nicotine supply is not enough to counteract the withdrawal symptoms—such as irritability, anxiety, intense cravings, and lack of concentration—the smoker’s brain will signal an overwhelming need for a cigarette, often leading to a quick return to tobacco. Healthcare providers often recommend chewing a piece every hour or every 90 minutes initially, or whenever an intense craving strikes, with a typical limit of 15 to 20 pieces per day. The nicotine gum should be chewed slowly for about 30 minutes, alternating between chewing and placing it between the cheek and teeth (“chew and park”).
Duration
The treatment is not meant to be indefinite. A standard course of treatment is about 12 weeks, followed by a gradual reduction. For instance, the user might gradually decrease the total number of pieces chewed per day over several weeks until they are no longer using the gum at all. It is paramount that users do not stop treatment prematurely. Stopping too soon, perhaps out of a false sense of security after a few weeks of success, exposes the person to the full force of lingering cravings and other nicotine withdrawal symptoms, dramatically increasing the risk of relapse. Some individuals may benefit from remaining on the gum for six months or more, as the small, controlled nicotine exposure is infinitely safer than returning to combustion.
Side effects
Side effects are usually mild and related to improper chewing technique. Chewing too fast can release too much nicotine at once, leading to minor stomach upset, hiccups, or a slight burning sensation in the mouth.
Special Populations and Public Health Impact
Nicotine gum is contraindicated for children under the age of 12.
Regarding pregnancy and breastfeeding, the general consensus is that while no nicotine product is entirely risk-free, the use of nicotine medications—including gum—is overwhelmingly safer than continued smoking. The carbon monoxide and thousands of toxins in smoke pose a massive risk to the fetus and infant, whereas NRT provides pure nicotine in a controlled manner. Use during pregnancy and breastfeeding should always be under medical supervision.
In the broader context of public health, nicotine medications like the gum represent the gold standard of tobacco harm reduction (THR). They are fundamentally distinct from the controversial use of nicotine delivery systems like e-cigarettes or heated tobacco products, as they are tested, regulated pharmaceuticals with decades of data proving their safety and efficacy for smoking cessation or reduction. The gum’s role is to help people sever the link between nicotine and the lethal practice of inhaling tobacco smoke.
Use the ‘Comments’ field below to share your experience with the nicotine gum or to suggest improvements to this article.
When it comes to quitting smoking, nicotine replacement therapies are not the only option available. For some smokers, particularly those who struggle with the psychological aspects of withdrawal, a medication alternative called bupropion, marketed under the name Zyban, can prove decisive.
Bupropion is not a nicotine substitute; it is an atypical antidepressant serendipitously discovered to be effective in smoking cessation. Its mechanism of action relies on modifying the levels of certain neurotransmitters in the brain, notably dopamine and norepinephrine. By acting on these chemical substances, Bupropion manages to reduce the intensity of the urge to smoke and alleviate the unpleasant symptoms of withdrawal, such as irritability, anxiety or depressed mood, which are often major factors leading to relapse.
Treatment Protocol and Dosage
Treatment with Bupropion is a commitment that generally lasts seven to nine weeks. It is crucial that the patient starts taking the medication one to two weeks before their set quit date. This preparation phase is essential to allow Bupropion to reach an optimal therapeutic concentration in the blood before complete cessation is initiated.
The usual dosage starts with one 150 mg tablet once daily for the first six days. From the seventh day, the dose is typically increased to 150 mg twice daily, ensuring that doses are spaced at least eight hours apart. It is imperative not to exceed 300 mg per day. This gradual increase is necessary to ensure maximum efficacy and to minimize side effects. The importance of a sufficient dose is central: if the smoker continues to feel a strong urge to smoke or significant withdrawal symptoms, it means the treatment is not fully effective, requiring careful medical monitoring to ensure the dosage is adequate and adhered to.
Experts emphasize the importance of never stopping treatment prematurely. Even after successfully quitting smoking, it is recommended to continue the therapy until the end of the prescribed cycle to consolidate cessation and prevent the risk of relapse, which is particularly high in the first few weeks.
For the user, the main recommendation is to strictly follow the doctor’s instructions, especially the timing of quitting smoking during the course of treatment. It is essential not to take a double dose if one is missed and to immediately inform the doctor of any changes in behavior or mood.
Efficacy and Profile of Beneficiaries
Clinical studies have shown that Bupropion roughly doubles the success rate of cessation compared to a placebo. Its efficacy is comparable to nicotine replacement therapy and is enhanced when combined with behavioral support.
Bupropion is particularly beneficial for a specific category of smokers: those with a history of mood disorders, especially depression. Since it has antidepressant activity, it helps not only with quitting smoking but also with preventing the onset or worsening of depressive symptoms that may occur during withdrawal.
If you feel depressed or have suicidal thoughts, consult your doctor immediately or go to the nearest hospital.
Side Effects and Contraindications
Like any medicinal treatment, Bupropion has side effects and strict contraindications. The most common side effects include dry mouth and, very frequently, insomnia, which is why the second daily dose should be taken in the early afternoon, far from bedtime.
The most severe contraindication concerns seizure disorders or any factor that lowers the seizure threshold (such as a head injury or alcohol abuse), as Bupropion slightly increases the risk of seizures. It is also strictly contraindicated in cases of eating disorders (anorexia or bulimia) or during abrupt alcohol or benzodiazepine withdrawal. A thorough medical examination is therefore essential before any prescription.
Serotonin syndrome (a potentially life-threatening condition) may occur, particularly when bupropion is taken in excessive doses or in combination with medications that affect serotonin levels.
Pregnancy, Breastfeeding, and User Recommendations
Regarding pregnancy and breastfeeding, Bupropion is generally not recommended. In the absence of robust safety data and considering potential risks to the fetus or infant, the first line of treatment for pregnant women remains the use of Nicotine Replacement Therapies, always under close medical supervision, or cessation without medicinal aid.
Use the “Comments” field below to share your experience with bupropion or to suggest improvements to this page.
Quitting smoking is not won solely by willpower, but largely through a correctly calibrated nicotine replacement strategy (NRT). For thousands of smokers NRT represents invaluable help, provided the correct dose is used—one that will extinguish the compelling urge to light a cigarette and other nicotine withdrawal symptoms. The equation is simple: the stronger the dependence, the greater the initial nicotine intake must be.
Determining the Right Dose: The Fagerström Test as a Guide
Assessing dependence is essential before starting effective treatment. Specialists often rely on two simple indicators: the number of cigarettes smoked per day and, most importantly, the time elapsed between waking up and the first cigarette.
A smoker who consumes fewer than 10 cigarettes per day or waits more than an hour after waking up for their first puff is considered weakly dependent. For them, lower doses of oral substitutes will often suffice, possibly combined with a low-dose patch.
Conversely, if consumption exceeds 15 cigarettes or if the first cigarette is smoked within 30 minutes of waking up, the dependence is judged to be strong to very strong. In this case, it is imperative to start with a high-dose patch (often 21 mg/24h or 25 mg/16h) and systematically combine it with a fast-acting oral form to manage unexpected craving spikes. For heavy smokers (more than 15 cigarettes), it is sometimes necessary to use two patches simultaneously to reach the required replacement dose.
Forms of Substitution
Each type of substitute delivers nicotine according to a different kinetic, justifying their combined or targeted use:
Patches: They ensure continuous, slow diffusion of nicotine into the body over sixteen or twenty-four hours. They constitute the background treatment, aiming to maintain stable nicotine levels and prevent constant withdrawal. Dosing typically ranges from 7 to 21 mg (or 10 to 25 mg for 16h), with a gradual weaning protocol over about eight to twelve weeks, reducing the dose in stages.
Gums, Micro-Tablets, and Lozenges: These oral forms deliver nicotine through the oral mucosa. They are essential for managing craving peaks. They are generally available in 2 mg doses for moderate dependence and 4 mg for strong dependence. They are taken on demand, typically eight to twelve times a day.
Mouth Sprays and Inhalers: These devices offer very rapid absorption, with the mouth spray being the quickest to counter a sudden urge, closely resembling the effect of a cigarette puff. They are used at a rate of one to two sprays per craving.
The duration of this replacement treatment should be maintained for at least three months, with the goal of stabilizing the cessation, and then gradually reducing the nicotine intake over several weeks, or even months, depending on the comfort of the ex-smoker. Treatment can extend up to six or even twelve months if necessary, to prevent relapse.
The Fear of Overdose: A Myth for the Smoker
The key point, often misunderstood by the general public, is that it is rarely possible to overdose on nicotine replacement therapy.
Healthcare professionals point out that the nicotine delivered by an NRT is absorbed more slowly and does not create the abrupt cerebral concentration peak of a cigarette. If the dosage is too high, the symptoms are generally mild and temporary: slight nausea, headaches, or palpitations. These signs are easily identifiable and simply call for a reduction in dose.
Conversely, it is under-dosing that represents the true pitfall of quitting. An insufficient dose fails to satisfy the nicotine deficiency, leaving the door open to withdrawal symptoms (irritability, anxiety, hunger, difficulty concentrating) and, inevitably, to relapse. The message is clear: it is better to start with a strong dose and adjust downwards, rather than condemning oneself to failure through timid dosing.
It is crucial not to stop treatment prematurely under the pretext of feeling “cured.” A hasty cessation, often after only a few weeks, exposes the former smoker to persistent craving and other nicotine withdrawal symptoms which can undermine efforts and lead to a return to smoking. Lasting success lies in this measured and fully dosed approach, taking the time for gradual reduction.
Use the Comments field below to share your experience or to suggest improvements to this article.